These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 294834)

  • 21. Acquisition of tuberculin sensitivity after injection of dialyzable transfer factor in sarcoidosis.
    Horsmanheimo M; Virolainen M
    Ann N Y Acad Sci; 1976; 278():129-35. PubMed ID: 1067003
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on the transfer factor of delayed hypersensitivity. Effect of dialysable leucocyte extracts from people of known tuberculin sensitivity on the migration of normal guinea-pig macrophages in the presence of antigen.
    Salaman MR
    Immunology; 1974 Jun; 26(6):1069-80. PubMed ID: 4859507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of human leukocyte dialysates containing transfer factor in the direct leukocyte migration inhibition (LMI) assay.
    Borkowsky W; Lawrence HS
    J Immunol; 1979 Oct; 123(4):1741-8. PubMed ID: 479597
    [No Abstract]   [Full Text] [Related]  

  • 24. THE IMMUNOLOGY AND CHEMISTRY OF TUBERCULIN. III. DIALYZABLE BCG CULTURE FILTRATE COMPONENTS OBTAINED BY SEPHEDEX CHROMATOGRAPHY AND FRACTIONAL DIALYSIS.
    CHAPARAS SD; BAER H
    Am Rev Respir Dis; 1964 Jul; 90():87-96. PubMed ID: 14178630
    [No Abstract]   [Full Text] [Related]  

  • 25. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
    Rocklin RE
    J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
    [No Abstract]   [Full Text] [Related]  

  • 26. Dialyzable leukocyte extract: partial purification of low-molecular-weight factors suppressing and enhancing lymphocyte transformation.
    Rosso di San Secondo VE; Lugaro G; Sirchia G
    J Exp Pathol; 1987; 3(4):425-7. PubMed ID: 3454803
    [No Abstract]   [Full Text] [Related]  

  • 27. THE ISOLATION FROM TUBERCULIN OF TWO DIFFERENT POLYSACCHARIDES HAVING ANAPHYLACTIC ACTIVITY. THEIR CHEMICAL AND BIOLOGIC PROPERTIES.
    YAMAMURA Y; OKADA Y; NAGAMATSU S; IMADA T
    Am Rev Respir Dis; 1965 Jun; 91():839-45. PubMed ID: 14294705
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of human transfer factor on the migration of guinea-pig macrophages: is there an antigen-specific activity?
    Sargent IL; Salaman MR
    Immunology; 1980 Sep; 41(1):227-35. PubMed ID: 6159314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Migration-inhibition response of peripheral leukocytes to tuberculin in cats sensitized with viable Mycobacterium bovis (BCG).
    Legendre AM; Mallmann VH; Michel RL
    Am J Vet Res; 1977 Jun; 38(6):819-22. PubMed ID: 327877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human transfer factor in vitro: identification of L-serine and glycine as components with augmenting effect in lymphocyte transformation assay.
    Uotila A; Marnela KM; Hamblin A; Krohn K
    Scand J Immunol; 1978; 7(6):495-502. PubMed ID: 684376
    [No Abstract]   [Full Text] [Related]  

  • 31. [In vitro transfer of immunity against PPD with dialyzable extract of leukocytes from human colostrum].
    Martínez-Cairo Cueto S; Alasio-Chávez C; Dávila Velázquez JR
    Rev Alerg; 1992; 39(6):126-32. PubMed ID: 1492196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of human dialyzable transfer factor from normal and chronic lymphoid leukemia sources.
    Goust JM; Marescot MR; Lesourd B; Doumercq S; Moulias R
    Biomedicine; 1976 Jan; 24(1):39-44. PubMed ID: 817750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dialyzable transfer factor in the treatment of human osteosarcoma: an analytic review.
    Fudenberg HH
    Ann N Y Acad Sci; 1976; 277(00):545-57. PubMed ID: 793487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro effect of transfer factor on active rosettes and leucocyte migration of patients with cancer.
    Nékám K; Kalmár L; Gergely P; Kelemen G; Fekete B; Láng I; Lévai J; Petrányi GY
    Clin Exp Immunol; 1977 Mar; 27(3):416-20. PubMed ID: 324669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro transfer of specific reactivity to cytomegalovirus and candida to cord blood leukocytes with dialyzable leukocyte extracts.
    Sirianni MC; Fiorilli M; Paná A; Pezzella M; Aiuti F
    Clin Immunol Immunopathol; 1979 Nov; 14(3):300-6. PubMed ID: 227634
    [No Abstract]   [Full Text] [Related]  

  • 36. Modulation of cell-mediated responses with dialyzable leukocyte extract containing transfer factor.
    Klesius PH
    Adv Exp Med Biol; 1981; 137():293-323. PubMed ID: 6174037
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of dialyzable products from human leukocyte extracts on cutaneous delayed-hypersensitivity response.
    Gottlieb AA; Maziarz GA; Tamaki N; Sutcliffe SB
    J Immunol; 1980 Feb; 124(2):885-92. PubMed ID: 7356716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Migration inhibitory effect of cell-free supernatants from tuberculin-stimulated cultures of human mononuclear leukocytes demonstrated by two-step MIF agarose assay.
    Clausen JE
    J Immunol; 1973 Feb; 110(2):546-51. PubMed ID: 4684036
    [No Abstract]   [Full Text] [Related]  

  • 39. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part II. Reconstituting effects dialyzable leukocyte lysates. (Second of three parts).
    Schindler TE; Baram P
    Allergol Immunopathol (Madr); 1980; 8(2):125-9. PubMed ID: 7457287
    [No Abstract]   [Full Text] [Related]  

  • 40. Isolation and characterization of immunopeptide from dialyzable leukocyte extract.
    Khan A; Garrison O; Hill JM; Antonetti A; Hill NO; Gracy RW
    Cell Immunol; 1980 Oct; 55(2):420-7. PubMed ID: 7428052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.